U.S. Markets closed

Wall Street Sees Upside of More than 17% for JNJ in the Next Year

Sarah Collins
Wall Street Sees Upside of More than 17% for JNJ in the Next Year

Over the last few quarters, Johnson & Johnson (JNJ) has seen a number of factors affecting investor sentiments surrounding its stock. The company, however, posted strong results for the first quarter on April 17, exceeding analysts’ estimates. In this article, we’ll take a look at analysts’ recommendations on JNJ for the next 12 months.